Terug
Dagbereik
€ 9,90
€ 10,36
52-Weeksbereik
€ 2,60
€ 11,23
Volume
172.106
50D / 200D Gem.
€ 10,15
/
€ 7,17
Vorige Slotkoers
€ 10,17
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,1 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | -30,7 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 15,67
+52.0%
Low: € 14,00
High: € 18,00
Forward WPA
-€ 1,36
Omzet Sch.
120 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,41
-€ 0,41 – -€ 0,41
|
220 M | 2 |
| FY2029 |
-€ 1,61
-€ 1,61 – -€ 1,61
|
69 M | 2 |
| FY2028 |
-€ 2,01
-€ 2,38 – -€ 1,61
|
8,5 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -54,55M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-30,70%
ROIC-27,96%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio17,14
Interest Coverage0,00
Waardering
P/E Ratio
-9,11
P/B Ratio2,99
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -69,79M |
| ROE | -30,70% | ROA | -30,85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -54,55M |
| ROIC | -27,96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 17,14 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,11 | P/B Ratio | 2,99 |
| P/S Ratio | N/A | PEG Ratio | -0,20 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 635,84M | Enterprise Value | 619,63M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -69,79M | -49,59M | -66,86M | -63,31M | -35,53M |
| EPS (Diluted) | -1,22 | -0,88 | -1,19 | -1,14 | -0,77 |
| Gross Profit | -622.000,0 | -596.000,0 | -537.000,0 | -466.000,0 | 0,0 |
| Operating Income | -79,47M | -62,38M | -78,19M | -67,59M | -35,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 226,20M | 252,09M | 289,64M | 341,14M | 390,56M |
| Total Liabilities | 13,70M | 10,00M | 11,96M | 13,83M | 8,43M |
| Shareholders' Equity | 212,50M | 242,10M | 277,69M | 327,31M | 382,13M |
| Total Debt | 645.000,0 | 2,33M | 3,05M | 3,69M | 3,63M |
| Cash & Equivalents | 16,86M | 22,56M | 21,20M | 26,50M | 298,57M |
| Current Assets | 223,78M | 248,04M | 284,58M | 335,12M | 385,44M |
| Current Liabilities | 13,06M | 8,46M | 9,62M | 10,78M | 5,28M |